Kurtoglu Metin

Cartesian Therapeutics, Inc. · Chief Technology Officer

Kurtoglu Metin is listed in public filings as officer: Chief Technology Officer. This Kurtoglu Metin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cartesian Therapeutics, Inc. (RNAC). Investors use Kurtoglu Metin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Cartesian Therapeutics, Inc.RNAC	$1.0M62.3k shares	SellJan 6, 2025	$41.4K2.5k shares	$16.83	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Cartesian Therapeutics, Inc.RNAC	$1.1M64.7k shares	SellJan 3, 2025	$40.4K2.4k shares	$16.72	--
Cartesian Therapeutics, Inc.RNAC	$802k47.4k shares	Grant / ExerciseJan 2, 2025	$802.5K47.4k shares	$16.93	--
Cartesian Therapeutics, Inc.RNAC	--67.1k shares	Grant / ExerciseJan 2, 2025	Disclosure amount unavailable16.1k shares	--	--
Cartesian Therapeutics, Inc.RNAC	$76k53.9k shares	Grant / ExerciseDec 10, 2024	$4.1K2.9k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$1.2M51k shares	SellDec 10, 2024	$70.6K2.9k shares	$24.35	--
Cartesian Therapeutics, Inc.RNAC	$1.4M55.6k shares	SellDec 9, 2024	$157.2K6.2k shares	$25.26	--
Cartesian Therapeutics, Inc.RNAC	$1.3M51k shares	SellDec 9, 2024	$117.3K4.5k shares	$25.83	--
Cartesian Therapeutics, Inc.RNAC	$87k61.8k shares	Grant / ExerciseDec 9, 2024	$15.2K10.8k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$851k51k shares	SellNov 21, 2024	$546.6K32.8k shares	$16.67	--
Cartesian Therapeutics, Inc.RNAC	$118k83.8k shares	Grant / ExerciseNov 21, 2024	$46.2K32.8k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$923k51k shares	SellNov 20, 2024	$1.8K100 shares	$18.09	--
Cartesian Therapeutics, Inc.RNAC	$884k51.1k shares	SellNov 20, 2024	$96.8K5.6k shares	$17.28	--
Cartesian Therapeutics, Inc.RNAC	$80k56.7k shares	Grant / ExerciseNov 20, 2024	$8.0K5.7k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$995k51k shares	SellNov 19, 2024	$3.9K200 shares	$19.50	--
Cartesian Therapeutics, Inc.RNAC	$72k51.2k shares	Grant / ExerciseNov 19, 2024	$282200 shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$948k51k shares	SellNov 18, 2024	$329.4K17.7k shares	$18.58	--
Cartesian Therapeutics, Inc.RNAC	$1.3M68.8k shares	SellNov 18, 2024	$303.2K16.7k shares	$18.19	--
Cartesian Therapeutics, Inc.RNAC	$120k85.4k shares	Grant / ExerciseNov 18, 2024	$48.5K34.4k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$878k51k shares	SellNov 15, 2024	$379.5K22.1k shares	$17.20	--
Cartesian Therapeutics, Inc.RNAC	$103k73.1k shares	Grant / ExerciseNov 15, 2024	$31.1K22.1k shares	$1.41	--
Cartesian Therapeutics, Inc.RNAC	$899k55k shares	SellNov 14, 2024	$357.6K21.9k shares	$16.33	--
Cartesian Therapeutics, Inc.RNAC	$871k51k shares	SellNov 14, 2024	$68.3K4k shares	$17.06	--
Cartesian Therapeutics, Inc.RNAC	$108k76.9k shares	Grant / ExerciseNov 14, 2024	$36.5K25.9k shares	$1.41	--